My Size, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by My Size, Inc. on July 13, 2023. The Company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market under the symbol "MYSZ". The report addresses a specific corporate governance event regarding executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a change to equity-based compensation terms rather than financial performance results.
Material Changes
On July 13, 2023, the Compensation Committee of the Board of Directors reduced the exercise price of outstanding stock options held by certain officers and directors. The reduction applies to an aggregate of 23,575 shares of common stock. The exercise price was lowered from $26.00 per share to $1.09 per share, which represented the closing price of the Company's shares on the date of the report.
Guidance, Outlook, and Management Commentary
The filing contains no guidance, outlook, or general management commentary regarding future business operations. The document details the specific allocation of the price reduction among named executive officers:
- Ronen Luzon (CEO and Director): 8,001 shares
- Or Kles (CFO): 5,760 shares
- Billy Pardo (COO and Chief Product Officer): 6,094 shares
No risks, contingencies, or unusual items beyond the compensation adjustment are disclosed in this text.
Key Facts for Investor Verification
- Verify the impact of the option repricing on the Company's share count and potential dilution.
- Confirm the current market price of MYSZ relative to the new $1.09 exercise price.
- Review the Company's stock option plan to understand the terms under which such a price reduction was authorized.
- Check for any subsequent filings regarding shareholder approval or regulatory responses to this compensation adjustment.